Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Deficit)

v3.22.0.1
Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Shares to Be Issued [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Nov. 30, 2019 0 10,402,184            
Balance at Nov. 30, 2019 $ 0 $ 10 $ 20 $ (888) $ 36,577 $ (37,662) $ (38) $ (1,981)
Issuance of common stock pursuant to exercise of stock options (in shares) 0 5,500           5,500
Issuance of common stock pursuant to exercise of stock options $ 0 $ 0 0 10 0 0 $ 10
Issuance of common stock for services (in shares) 0 87,783            
Issuance of common stock for services $ 0 $ 0 0 0 429 0 0 429
Issuance of common stock for intellectual property (in shares) 0 386,681            
Issuance of common stock for intellectual property $ 0 $ 0 0 0 693 0 0 693
Issuance of common stock – Roboro acquisition (in shares) 0 138,889            
Issuance of common stock – Roboro acquisition $ 0 $ 0 0 0 554 0 0 554
Issuance of warrants upon conversion of the convertible notes $ 0 $ 0 0 0 240 0 0 240
Issuance of Series A preferred stock upon conversion of the convertible notes (in shares) 1,391 0            
Issuance of Series A preferred stock upon conversion of the convertible notes $ 0 $ 0 0 0 11,562 0 0 11,562
Issuance of warrants for payment of accrued interest 0 0 0 0 125 0 0 125
Stock—based compensation $ 0 $ 0 0 0 1,252 0 0 1,252
Cancellation of shares (in shares) 0 (370,000)            
Cancellation of shares $ 0 $ 0 0 888 (884) 0 0 4
Stock to be issued settled in cash $ 0 $ 0 (20) 0 0 0 0 (20)
Warrant exercises (in shares) 0 4,200,986            
Warrant exercises $ 0 $ 5 0 0 8,023 0 0 8,028
Net income (loss) 0 0 0 0 0 (12,553) 0 (12,553)
Foreign exchange translation adjustment $ 0 $ 0 0 0 0 0 66 66
Balance (in shares) at Nov. 30, 2020 1,391 14,852,023            
Balance at Nov. 30, 2020 $ 0 $ 15 0 0 58,581 (50,215) 28 $ 8,409
Issuance of common stock pursuant to exercise of stock options (in shares)               81,182
Issuance of common stock pursuant to exercise of stock options $ 0 $ 0 0 0 104 0 0 $ 104
Issuance of Series A preferred stock upon conversion of the convertible notes (in shares) (1,391) 5,332,147            
Issuance of Series A preferred stock upon conversion of the convertible notes $ 0 $ 5 0 0 1,038 0 0 1,043
Stock—based compensation 0 0 0 0 3,150 0 0 3,150
Warrant exercises 0 0 0 0 1,277 0 0 1,277
Net income (loss) 0 0 0 0 0 (3,283) 0 (3,283)
Foreign exchange translation adjustment $ 0 $ 0 0 0 0 0 (44) (44)
Issuance of common stock pursuant to exercise of restricted stock units (in shares) 0 35,000            
Issuance of common stock pursuant to exercise of restricted stock units $ 0 $ 0 0 0 533 0 0 533
Dividends declared on preferred stock $ 0 $ 0 0 0 (1,043) 0 0 (1,043)
Sale of common stock, net of underwriting discount and offering costs (in shares) 0 2,875,000            
Sale of common stock, net of underwriting discount and offering costs $ 0 $ 3 0 0 55,949 0 0 55,952
Balance (in shares) at Nov. 30, 2021 0 23,754,096            
Balance at Nov. 30, 2021 $ 0 $ 23 $ 0 $ 0 $ 119,589 $ (53,498) $ (16) $ 66,098